SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-047688
Filing Date
2024-04-24
Accepted
2024-04-24 17:00:14
Documents
1
Period of Report
2024-04-24
Effectiveness Date
2024-04-24

Document Format Files

Seq Description Document Type Size
1 ARS ovid_2024_ars.pdf ARS 1746046
  Complete submission text file 0000950170-24-047688.txt   2406120
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38085 | Film No.: 24871357
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)